Nano Dimension Signs Non-Binding Term Sheet to Merge with Infinite Epigenetics

Corporate ActionM&A · Partnership
โดย Insider Monkey·Read original
Summary · why it matters

Nano Dimension has entered into a non-binding term sheet for a proposed business combination with Infinite Epigenetics. The deal would see Nano Dimension or a successor public company acquire 100% of Infinite Epigenetics through a merger or similar structure, with the combined company operating under the Infinite Epigenetics name and trading on Nasdaq under the proposed ticker IEAI. Existing Nano Dimension shareholders are expected to retain a minority stake based on a 20% premium to Nano Dimension's estimated net cash at closing, and the combined company is expected to have over 400 million dollars in cash at closing. Pre-combination Nano Dimension shareholders would also receive a contingent value right tied to net proceeds from the sale of Nano legacy assets. The term sheet includes a 30-day mutual exclusivity period for due diligence and finalization of a definitive agreement, with Infinite Epigenetics co-founder and CEO Matthew Dawson expected to lead the combined company. Separately, Stratasys announced last month a definitive agreement to acquire MarkForged, a wholly owned subsidiary of Nano Dimension, in an all-cash deal valued at 42.5 million dollars, with MarkForged generating approximately 70 million dollars in revenue in 2025.

Impact on stocks 2

Information Technology▲ · 2 stocks
Nano Dimension Ltd
NNDM
± MixedCapitalrelevance

Nano Dimension signs non-binding term sheet to merge with Infinite Epigenetics; existing shareholders get minority stake and contingent value right, but deal structure and outcome uncertain.

Off-coverage companies 2

Infinite EpigeneticsPrivate▲ Positive
Capitalrelevance

Infinite Epigenetics to be acquired by Nano Dimension, becoming the surviving public company with CEO leading combined entity.

MarkforgedPrivate▲ Positive
Capitalrelevance

Stratasys acquires MarkForged for $42.5M; MarkForged generated ~$70M revenue in 2025, implying a favorable valuation for the sale.

© 2026 MarketDXNews